Peripheral arterial disease. Secondary prevention, medical therapy, revascularization

被引:0
作者
Schulte, K. -L. [1 ]
机构
[1] Evangel Krankenhaus Konigin Elisabeth Herzberge, Gefasszentrum Berlin, Med Klin, Akad Lehrkrankenhaus Charite, D-10365 Berlin, Germany
来源
INTERNIST | 2009年 / 50卷 / 08期
关键词
Peripheral arterial disease; Intermittent claudication; Exercise therapy; Secondary prevention; Endovascular therapy; NITINOL STENTS; ANGIOPLASTY; PREVALENCE; IMPLANTATION; METAANALYSIS; LESIONS; TRIAL;
D O I
10.1007/s00108-009-2365-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with peripheral arterial disease have a high risk of cardiovascular morbidity and mortality. Thus, antiplatelet drugs, antidiabetic, antihypertensive and antilipemic agents should be administered early on. Smoking cessation has to be encouraged and supported. In case of significant reduction of walking distance with impaired quality of life structured and supervised exercise training as well as vasoactive substances have to be offered. If technically feasible and critically discussed with the patient revascularization procedures of the aorto-iliac and the femoropopliteal segment may be performed. In patients with critical limb ischemia, all options for vascularisation have to be utilized as the main goal is limb salvage. As medication, only prostanoids have to be considered.
引用
收藏
页码:927 / +
页数:7
相关论文
共 26 条
  • [1] [Anonymous], DIAGN MAN PER ART DI
  • [2] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [3] Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
    Bradbury, AW
    Ruckley, CV
    Fowkes, FGR
    Forbes, JF
    Gillespie, I
    Adam, DJ
    Beard, JD
    Cleveland, T
    Bell, J
    Raab, G
    Storkey, H
    [J]. LANCET, 2005, 366 (9501) : 1925 - 1934
  • [4] THE PREVALENCE OF PERIPHERAL ARTERIAL-DISEASE IN A DEFINED POPULATION
    CRIQUI, MH
    FRONEK, A
    BARRETTCONNOR, E
    KLAUBER, MR
    GABRIEL, S
    GOODMAN, D
    [J]. CIRCULATION, 1985, 71 (03) : 510 - 515
  • [5] Naftidrofuryl for intermittent claudication
    De Backer, T. L. M.
    Stichele, Vander R.
    Lehert, P.
    Van Bortel, L.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [6] High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
    Diehm, C
    Schuster, A
    Allenberg, JR
    Darius, H
    Haberl, R
    Lange, S
    Pittrow, D
    von Stritzky, B
    Tepohl, G
    Trampisch, HJ
    [J]. ATHEROSCLEROSIS, 2004, 172 (01) : 95 - 105
  • [7] *DTSCH GES ANG GES, 2009, VASA S, V38, P1
  • [8] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Gaede, P
    Vedel, P
    Larsen, N
    Jensen, GVH
    Parving, H
    Pedersen, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) : 383 - 393
  • [9] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    Gent, M
    Beaumont, D
    Blanchard, J
    Bousser, MG
    Coffman, J
    Easton, JD
    Hampton, JR
    Harker, LA
    Janzon, L
    Kusmierek, JJE
    Panak, E
    Roberts, RS
    Shannon, JS
    Sicurella, J
    Tognoni, G
    Topol, EJ
    Verstraete, M
    Warlow, C
    [J]. LANCET, 1996, 348 (9038) : 1329 - 1339
  • [10] The Adjuvant Benefit of Angioplasty in Patients with Mild to Moderate Intermittent Claudication (MIMIC) Managed by Supervised Exercise, Smoking Cessation Advice and Best Medical Therapy: Results from Two Randomised Trials for Stenotic Femoropopliteal and Aortoiliac Arterial Disease The MIMIC Trial Participants (See Appendix 1)
    Greenhalgh, R. M.
    Belch, J. J. F.
    Brown, L. C.
    Gaines, P. A.
    Gao, L.
    Reise, J. A.
    Thompson, S. G.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (06) : 680 - 688